Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 53 | 2024 | 5221 | 4.300 |
Why?
|
Lung Neoplasms | 72 | 2024 | 13102 | 3.880 |
Why?
|
Artificial Intelligence | 24 | 2024 | 2214 | 2.700 |
Why?
|
Tomography, X-Ray Computed | 56 | 2024 | 20129 | 2.080 |
Why?
|
Image Processing, Computer-Assisted | 29 | 2024 | 8949 | 2.070 |
Why?
|
Diagnostic Imaging | 13 | 2023 | 3507 | 1.440 |
Why?
|
Fluorodeoxyglucose F18 | 18 | 2020 | 2016 | 1.270 |
Why?
|
Algorithms | 24 | 2024 | 13881 | 1.220 |
Why?
|
Head and Neck Neoplasms | 13 | 2023 | 2734 | 1.130 |
Why?
|
Positron-Emission Tomography | 30 | 2020 | 6234 | 1.120 |
Why?
|
Radiometry | 4 | 2018 | 800 | 1.110 |
Why?
|
Tumor Burden | 20 | 2020 | 1915 | 0.940 |
Why?
|
Radiosurgery | 6 | 2022 | 1329 | 0.900 |
Why?
|
Adenocarcinoma | 7 | 2017 | 6364 | 0.880 |
Why?
|
Glioblastoma | 5 | 2022 | 3481 | 0.840 |
Why?
|
Oropharyngeal Neoplasms | 7 | 2023 | 477 | 0.830 |
Why?
|
Neoplasms | 24 | 2023 | 21683 | 0.820 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2018 | 719 | 0.780 |
Why?
|
Rectal Neoplasms | 7 | 2020 | 1206 | 0.770 |
Why?
|
Medical Oncology | 4 | 2021 | 2265 | 0.760 |
Why?
|
Radiopharmaceuticals | 16 | 2020 | 2645 | 0.760 |
Why?
|
Magnetic Resonance Imaging | 18 | 2023 | 35421 | 0.680 |
Why?
|
Pattern Recognition, Automated | 6 | 2018 | 1005 | 0.660 |
Why?
|
Reproducibility of Results | 30 | 2024 | 19905 | 0.650 |
Why?
|
Prognosis | 33 | 2023 | 29063 | 0.630 |
Why?
|
Chest Pain | 3 | 2021 | 1114 | 0.600 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2020 | 450 | 0.590 |
Why?
|
Semantics | 2 | 2017 | 584 | 0.590 |
Why?
|
Radiology | 5 | 2023 | 2100 | 0.580 |
Why?
|
Mutation | 10 | 2023 | 29786 | 0.560 |
Why?
|
Phenotype | 8 | 2020 | 16365 | 0.560 |
Why?
|
Carcinoma, Large Cell | 1 | 2016 | 113 | 0.550 |
Why?
|
Coronary Vessels | 5 | 2022 | 3107 | 0.550 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2017 | 4034 | 0.540 |
Why?
|
Automation | 2 | 2018 | 584 | 0.530 |
Why?
|
Humans | 160 | 2024 | 744343 | 0.530 |
Why?
|
Contrast Media | 6 | 2017 | 5300 | 0.520 |
Why?
|
Radiation Oncology | 6 | 2020 | 555 | 0.520 |
Why?
|
Lung Diseases | 2 | 2023 | 1886 | 0.520 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 1184 | 0.510 |
Why?
|
Imaging, Three-Dimensional | 6 | 2017 | 4042 | 0.500 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9239 | 0.490 |
Why?
|
Neoadjuvant Therapy | 5 | 2020 | 2728 | 0.490 |
Why?
|
Genomics | 5 | 2018 | 5720 | 0.470 |
Why?
|
Zirconium | 2 | 2016 | 100 | 0.460 |
Why?
|
Lung | 8 | 2024 | 9856 | 0.450 |
Why?
|
Neoplasm Staging | 18 | 2020 | 11031 | 0.440 |
Why?
|
Brain Neoplasms | 4 | 2024 | 8863 | 0.440 |
Why?
|
Neoplasm Metastasis | 7 | 2023 | 4851 | 0.420 |
Why?
|
Thorax | 5 | 2024 | 547 | 0.420 |
Why?
|
Genetic Heterogeneity | 3 | 2019 | 733 | 0.420 |
Why?
|
Radioactive Tracers | 1 | 2012 | 72 | 0.410 |
Why?
|
Aged | 53 | 2022 | 163280 | 0.400 |
Why?
|
Radiography, Thoracic | 3 | 2023 | 1265 | 0.380 |
Why?
|
Aged, 80 and over | 25 | 2020 | 57776 | 0.370 |
Why?
|
Medical Informatics | 3 | 2017 | 745 | 0.360 |
Why?
|
Middle Aged | 52 | 2023 | 213383 | 0.360 |
Why?
|
Area Under Curve | 6 | 2016 | 1654 | 0.360 |
Why?
|
Quinazolines | 1 | 2016 | 1356 | 0.360 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 8 | 2020 | 1624 | 0.340 |
Why?
|
Computational Biology | 4 | 2021 | 3521 | 0.340 |
Why?
|
Male | 68 | 2024 | 350118 | 0.340 |
Why?
|
Image Enhancement | 2 | 2011 | 2921 | 0.330 |
Why?
|
Meningioma | 1 | 2017 | 1209 | 0.330 |
Why?
|
Meningeal Neoplasms | 1 | 2017 | 1241 | 0.320 |
Why?
|
Software | 9 | 2021 | 4443 | 0.320 |
Why?
|
Gadolinium DTPA | 2 | 2009 | 836 | 0.320 |
Why?
|
Female | 65 | 2024 | 380194 | 0.310 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.310 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2038 | 0.300 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2020 | 3327 | 0.300 |
Why?
|
Radioisotopes | 1 | 2008 | 499 | 0.300 |
Why?
|
Developing Countries | 1 | 2019 | 2815 | 0.290 |
Why?
|
Pharmacogenetics | 4 | 2015 | 675 | 0.290 |
Why?
|
Radiography | 2 | 2017 | 7023 | 0.290 |
Why?
|
High-Throughput Screening Assays | 2 | 2014 | 944 | 0.290 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 388 | 0.290 |
Why?
|
National Cancer Institute (U.S.) | 3 | 2023 | 288 | 0.280 |
Why?
|
Retrospective Studies | 30 | 2024 | 77449 | 0.280 |
Why?
|
Public Health | 1 | 2019 | 2603 | 0.280 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15165 | 0.280 |
Why?
|
Models, Biological | 5 | 2018 | 9583 | 0.260 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.250 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5319 | 0.250 |
Why?
|
Microcirculation | 1 | 2009 | 1286 | 0.250 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.250 |
Why?
|
Neoplasm Proteins | 2 | 2023 | 3703 | 0.240 |
Why?
|
Temporal Muscle | 1 | 2023 | 37 | 0.230 |
Why?
|
Survival Rate | 6 | 2019 | 12788 | 0.230 |
Why?
|
Growth Charts | 1 | 2023 | 61 | 0.230 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9274 | 0.220 |
Why?
|
Esophagitis | 1 | 2023 | 152 | 0.210 |
Why?
|
HLA Antigens | 1 | 2017 | 1381 | 0.200 |
Why?
|
Predictive Value of Tests | 10 | 2021 | 15076 | 0.200 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39050 | 0.200 |
Why?
|
ROC Curve | 4 | 2019 | 3527 | 0.200 |
Why?
|
Lymphatic Metastasis | 3 | 2019 | 2924 | 0.200 |
Why?
|
Risk Assessment | 7 | 2021 | 23338 | 0.190 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1270 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8428 | 0.190 |
Why?
|
Antineoplastic Agents | 6 | 2018 | 13695 | 0.190 |
Why?
|
Melanoma | 1 | 2019 | 5510 | 0.190 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2540 | 0.180 |
Why?
|
Cardiac Volume | 1 | 2021 | 210 | 0.180 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1583 | 0.180 |
Why?
|
Papillomavirus Infections | 2 | 2023 | 1587 | 0.180 |
Why?
|
Observer Variation | 3 | 2016 | 2593 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6538 | 0.170 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1917 | 0.170 |
Why?
|
Coronary Angiography | 3 | 2021 | 4577 | 0.170 |
Why?
|
Natural Language Processing | 2 | 2024 | 1041 | 0.170 |
Why?
|
Adult | 21 | 2021 | 214055 | 0.160 |
Why?
|
Calcium | 3 | 2022 | 5756 | 0.160 |
Why?
|
Radiation Injuries | 3 | 2019 | 1180 | 0.160 |
Why?
|
Sarcopenia | 1 | 2023 | 368 | 0.160 |
Why?
|
Toxicogenetics | 2 | 2014 | 31 | 0.160 |
Why?
|
Nomograms | 2 | 2022 | 228 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 551 | 0.150 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 221 | 0.150 |
Why?
|
Papillomaviridae | 3 | 2020 | 1119 | 0.150 |
Why?
|
Heart Diseases | 2 | 2021 | 2788 | 0.150 |
Why?
|
Coronary Artery Disease | 4 | 2021 | 6487 | 0.140 |
Why?
|
Radiotherapy Dosage | 7 | 2018 | 2879 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12245 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 287 | 0.140 |
Why?
|
Chromosomal Instability | 1 | 2017 | 184 | 0.140 |
Why?
|
Survival Analysis | 4 | 2017 | 10252 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2019 | 326 | 0.140 |
Why?
|
Pericardium | 1 | 2020 | 667 | 0.130 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2219 | 0.130 |
Why?
|
Treatment Outcome | 12 | 2021 | 63114 | 0.130 |
Why?
|
Decision Support Systems, Clinical | 2 | 2016 | 1164 | 0.130 |
Why?
|
Prospective Studies | 12 | 2021 | 53288 | 0.130 |
Why?
|
Language | 1 | 2024 | 1471 | 0.120 |
Why?
|
Early Detection of Cancer | 4 | 2022 | 3086 | 0.120 |
Why?
|
False Positive Reactions | 1 | 2017 | 981 | 0.120 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2014 | 71 | 0.120 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14722 | 0.120 |
Why?
|
Nuclear Medicine | 1 | 2016 | 233 | 0.120 |
Why?
|
Pulmonary Veins | 1 | 2019 | 761 | 0.120 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1504 | 0.120 |
Why?
|
Uncertainty | 1 | 2018 | 734 | 0.110 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2014 | 145 | 0.110 |
Why?
|
Pneumonectomy | 2 | 2018 | 1094 | 0.110 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.110 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2019 | 934 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1692 | 0.110 |
Why?
|
Forecasting | 2 | 2018 | 2951 | 0.100 |
Why?
|
Risk Factors | 11 | 2022 | 72290 | 0.100 |
Why?
|
Radiation Dosage | 4 | 2021 | 1928 | 0.100 |
Why?
|
Diffusion of Innovation | 2 | 2011 | 725 | 0.100 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1758 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2018 | 1275 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1533 | 0.100 |
Why?
|
Evolution, Molecular | 2 | 2017 | 1940 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2010 | 2886 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2375 | 0.100 |
Why?
|
Pneumonia | 1 | 2023 | 2133 | 0.100 |
Why?
|
Prostate | 1 | 2019 | 1774 | 0.090 |
Why?
|
Heart | 2 | 2021 | 4467 | 0.090 |
Why?
|
Radiotherapy, Conformal | 2 | 2010 | 548 | 0.090 |
Why?
|
Glioma | 2 | 2024 | 3401 | 0.090 |
Why?
|
Drug Administration Routes | 1 | 2010 | 153 | 0.090 |
Why?
|
Respiration | 1 | 2017 | 1653 | 0.090 |
Why?
|
Models, Statistical | 2 | 2018 | 5102 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12354 | 0.090 |
Why?
|
Nitroimidazoles | 1 | 2010 | 106 | 0.090 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.080 |
Why?
|
Pilot Projects | 3 | 2021 | 8324 | 0.080 |
Why?
|
Genetic Markers | 1 | 2015 | 2634 | 0.080 |
Why?
|
Technology Assessment, Biomedical | 1 | 2011 | 306 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.080 |
Why?
|
Hepatocytes | 1 | 2015 | 1211 | 0.080 |
Why?
|
Programming Languages | 2 | 2021 | 133 | 0.080 |
Why?
|
Injections, Intra-Arterial | 1 | 2008 | 193 | 0.080 |
Why?
|
Research Design | 3 | 2022 | 5987 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2737 | 0.080 |
Why?
|
Cell Lineage | 1 | 2017 | 2504 | 0.080 |
Why?
|
Cell Cycle | 1 | 2016 | 2967 | 0.080 |
Why?
|
Computer Simulation | 3 | 2011 | 6196 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11524 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1519 | 0.080 |
Why?
|
Databases, Factual | 4 | 2021 | 7729 | 0.080 |
Why?
|
Proteomics | 3 | 2023 | 3638 | 0.070 |
Why?
|
Immunotherapy | 2 | 2022 | 4445 | 0.070 |
Why?
|
Deoxycytidine | 1 | 2011 | 826 | 0.070 |
Why?
|
Antigens, Neoplasm | 3 | 2023 | 1988 | 0.070 |
Why?
|
Carboxylic Acids | 1 | 2007 | 97 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1058 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 2015 | 1179 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2014 | 16689 | 0.070 |
Why?
|
United States | 8 | 2023 | 69872 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3255 | 0.070 |
Why?
|
Mass Screening | 2 | 2019 | 5255 | 0.070 |
Why?
|
Pharmaceutical Preparations | 1 | 2014 | 1071 | 0.070 |
Why?
|
Gene Expression Profiling | 6 | 2021 | 9438 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 684 | 0.060 |
Why?
|
Cisplatin | 1 | 2011 | 1662 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2008 | 2327 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3586 | 0.060 |
Why?
|
Staining and Labeling | 1 | 2008 | 1100 | 0.060 |
Why?
|
Gadolinium | 1 | 2009 | 952 | 0.060 |
Why?
|
Triazoles | 1 | 2010 | 911 | 0.060 |
Why?
|
Workflow | 2 | 2020 | 847 | 0.060 |
Why?
|
Disease Progression | 2 | 2017 | 13284 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.060 |
Why?
|
Femoral Artery | 1 | 2008 | 845 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11366 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 8987 | 0.060 |
Why?
|
Rectum | 1 | 2008 | 904 | 0.060 |
Why?
|
Phylogeny | 2 | 2023 | 2803 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2008 | 1254 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.050 |
Why?
|
Silver | 1 | 2023 | 122 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 15519 | 0.050 |
Why?
|
Decision Support Techniques | 3 | 2020 | 1956 | 0.050 |
Why?
|
Prevalence | 2 | 2019 | 15226 | 0.050 |
Why?
|
Models, Genetic | 1 | 2013 | 3494 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6895 | 0.050 |
Why?
|
Phantoms, Imaging | 3 | 2020 | 2480 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.050 |
Why?
|
Tomography, Emission-Computed | 3 | 2010 | 1144 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2017 | 1284 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 204 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2751 | 0.050 |
Why?
|
Time Factors | 3 | 2019 | 40075 | 0.050 |
Why?
|
Mice, Nude | 1 | 2007 | 3689 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2012 | 3589 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2009 | 5974 | 0.050 |
Why?
|
Apoptosis | 1 | 2016 | 9727 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1941 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 506 | 0.040 |
Why?
|
Computer Graphics | 1 | 2021 | 361 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2007 | 3557 | 0.040 |
Why?
|
Computer Security | 1 | 2021 | 262 | 0.040 |
Why?
|
Industry | 1 | 2011 | 365 | 0.040 |
Why?
|
Biomedical Research | 3 | 2021 | 3309 | 0.040 |
Why?
|
Germany | 1 | 2020 | 862 | 0.040 |
Why?
|
Signal Transduction | 3 | 2016 | 23403 | 0.040 |
Why?
|
Calibration | 1 | 2020 | 816 | 0.040 |
Why?
|
Benchmarking | 1 | 2024 | 1042 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9687 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4186 | 0.040 |
Why?
|
Angina Pectoris | 1 | 2021 | 977 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2021 | 841 | 0.040 |
Why?
|
Organotechnetium Compounds | 1 | 2016 | 137 | 0.040 |
Why?
|
Limit of Detection | 1 | 2017 | 265 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11124 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2014 | 1783 | 0.030 |
Why?
|
Death | 1 | 2021 | 678 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.030 |
Why?
|
Cell Tracking | 1 | 2017 | 145 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2971 | 0.030 |
Why?
|
Selection Bias | 1 | 2016 | 371 | 0.030 |
Why?
|
Entropy | 1 | 2015 | 209 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1431 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1681 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2024 | 2043 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 314 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2015 | 280 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.030 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2401 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1692 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 459 | 0.030 |
Why?
|
Logistic Models | 2 | 2022 | 13408 | 0.030 |
Why?
|
Patient Care | 1 | 2018 | 640 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4669 | 0.030 |
Why?
|
Animals | 5 | 2015 | 168757 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8642 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2716 | 0.020 |
Why?
|
Keratin-19 | 1 | 2010 | 33 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2478 | 0.020 |
Why?
|
Mice | 2 | 2008 | 81183 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5172 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.020 |
Why?
|
Postoperative Care | 1 | 2017 | 1486 | 0.020 |
Why?
|
Patient Selection | 1 | 2022 | 4215 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2010 | 288 | 0.020 |
Why?
|
Carbonic Anhydrases | 1 | 2010 | 115 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 5985 | 0.020 |
Why?
|
Folic Acid | 1 | 2016 | 1300 | 0.020 |
Why?
|
Cell Survival | 2 | 2010 | 5882 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2010 | 424 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2010 | 349 | 0.020 |
Why?
|
Device Approval | 1 | 2011 | 163 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2009 | 380 | 0.020 |
Why?
|
Iohexol | 1 | 2010 | 196 | 0.020 |
Why?
|
Osteopontin | 1 | 2010 | 296 | 0.020 |
Why?
|
Liver | 2 | 2015 | 7474 | 0.020 |
Why?
|
Rats | 2 | 2015 | 24260 | 0.020 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2010 | 358 | 0.020 |
Why?
|
Sarcoma | 1 | 2020 | 1897 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3279 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4931 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2212 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2010 | 690 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12959 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 675 | 0.020 |
Why?
|
Molecular Weight | 1 | 2009 | 2255 | 0.020 |
Why?
|
Artifacts | 1 | 2015 | 1904 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1484 | 0.020 |
Why?
|
Conflict of Interest | 1 | 2011 | 544 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.020 |
Why?
|
Child | 2 | 2024 | 77709 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 973 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5078 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Treatment Failure | 1 | 2010 | 2618 | 0.020 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2505 | 0.010 |
Why?
|
Remission Induction | 1 | 2009 | 2386 | 0.010 |
Why?
|
Propensity Score | 1 | 2010 | 1781 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1584 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4894 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7799 | 0.010 |
Why?
|
Aging | 1 | 2021 | 8664 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7722 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1471 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3200 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10397 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6114 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11727 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19229 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15997 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3778 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
Heart Failure | 1 | 2021 | 10900 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15540 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.010 |
Why?
|
Inflammation | 1 | 2010 | 10638 | 0.010 |
Why?
|